12 March 2020
Sofitel Legend Amsterdam The Grand
If you are interested in sponsoring the 2020 BioCapital Europe Conference please contact firstname.lastname@example.org or call +44 0750 0797 372
Event Organised by
LSP (Life Sciences Partners)
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
For more information, please visit lspvc.com.
Gold Sponsors 2019 – Preconference drinks & fireside chat
LifeSci Advisors (www.lifesciadvisors.com) is the largest investor relations firm in the healthcare sector and provides life science companies tailored solutions to global investor access and communication. Our experienced team is made up of former healthcare equity sales professionals, investment bankers, portfolio managers – all with 15+ years of Wall Street experience – plus scientists, equity analysts and journalists. We leverage our domain expertise to secure quality, one-on-one time with investors for our clients. We understand our clients’ financial, R&D, regulatory, and commercial goals and challenges, and help them not only to win valuable face time with leading investors but also to communicate in ways that resonate with specialist healthcare investors. LifeSci is active in and has offices in multiple cities in the U.S, Europe, Israel and China.
Lunch Sponsor 2019
Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry in order to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. We also work with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolios companies. The largest dedicated Life Science search boutique in North America and Europe, we work in a unique way. We share knowledge and connections across the globe, as one team with one goal. To bring clients the world’s best talent.
Tea & Coffee Breaks Sponsor 2019
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
How EY’s Global Life Sciences Sector can help your business
Life sciences companies — from emerging start-ups to multinational enterprises — face new challenges in a rapidly changing health care ecosystem. Payers and regulators are increasing scrutiny and accelerating the transition to value and outcomes. Big data and patient-empowering technologies are driving new approaches and enabling transparency and consumerism. Players from other sectors are entering health care, making collaborations increasingly complex. These trends challenge every aspect of the life sciences business model, from R&D to marketing.
Our Global Life Sciences Sector brings together a worldwide network — more than 7,000 sector-focused assurance, tax, transaction and advisory professionals — to anticipate trends, identify their implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.
Russell Reynolds Associates
Drinks Reception Sponsor 2019
Loyens & Loeff
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance. Our Investment Management practice also works closely with our firm’s Pharmaceuticals & Life Sciences Team and Healthcare Team, offering our clients in-depth sector knowledge, which enables us to offer truly integrated services.
Thanks to our closely collaborating legal and tax practices and our extensive sector knowledge, we have built up a unique and very solid position in the market, which enables us to effectively structuring and supervising both domestic and international matters.
Contributing Sponsors 2019
Allen & Overy
Allen & Overy Amsterdam is known for its individual experts and their ability to join forces, across practice areas and borders, to get deals done and to find solutions in highly complex cases. We are universally recognised market leaders in corporate transactions, banking & capital markets, governance & regulatory and disputes. Our global span of 44 offices with over 5,500 people and 550 partners covers established and emerging economies in the West and East and contains a network of over 90 highly experienced lawyers in life sciences.
We offer full-service and dedicated support for companies in the life sciences sector covering investments, start-ups and (venture) financing, mergers & acquisitions, IPO’s, capital market transactions, funds, intellectual property (contentious and non-contentious), regulatory and dispute resolution. Our experts have in-depth knowledge, presence and focus in the Dutch market and work together cross practice on a day-to-day basis. We cover all relevant areas, including pharma, biotech, medical devices, connected health, and consumer healthcare. Our unique experience of working with all relevant parties in the sector, from leading pharmaceutical, generics, biotech and medtech companies, as well as investors, universities and financial institutions has enhanced our ability to identify and anticipate the latest trends in the life sciences sector. Legal and regulatory developments in the Life Sciences sector are the topic of our dedicated blog, the Life Sciences Hub, and our CRISPR microsite, focusing on CRISPR related topics.
As a global top 40 law practice, Eversheds Sutherland provides legal services to a global client base ranging from small and mid-sized businesses to the largest multinationals, acting for 72 of the Fortune 100, 61 of the FTSE 100 and 120 of the Fortune 200.
With more than 2,800 lawyers, Eversheds Sutherland operates in 67 offices in 34 jurisdictions across Africa, Asia, Europe, the Middle East and the United States. In addition, a network of more than 200 related law firms, including formalized alliances in Latin America, Asia Pacific and Africa, provide support around the globe.
Our (international) Life Sciences Group is a highly recommended, multi-disciplinary legal team with extensive experience of the issues faced by the different sectors of the pharmaceutical, biosciences and medical devices industries. Specialists across the Group have extensive experience of the issues faced by the international biomedical industry with patent specialists across the world providing cutting-edge advice to the life sciences sector. Our Life Sciences Group is highly integrated and are able to advise you in multiple jurisdictions.
At Goodwin, we use law to achieve unprecedented results for our clients. Our 1,000 plus lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigations and world-class advisory services in the financial, life sciences, private equity, real estate, and technology industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. Our integrated, full-service team with focused industry expertise helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle, and serve all legal needs of life sciences clients — corporate, partnering, regulatory, intellectual property and litigation. To learn more, visit us at www.goodwinlaw.com and follow us on Twitter at @goodwinlaw and on LinkedIn.
Kempen Corporate Finance
Kempen Corporate Finance is uniquely positioned as a dedicated specialist adviser in the life sciences & healthcare sector. Over the past years, we have built a strong position and extensive track-record in European IPOs and other capital market transactions and have emerged as a trusted adviser in various cross-border mergers & acquisitions and other advisory services. We combine our in depth knowledge of the financial sector with a scientific background and extensive business experience.
About Odgers Berndtson
For over 50 years Odgers Berndtson has helped some of the world’s leading organisations find the senior talent to drive their agendas.
We deliver executive search, assessment and development to organisations varying in size, structure and maturity. We do this across all areas of the commercial, public and not-for-profit sectors, drawing on the experience of more than 250 Partners and their teams in 32 countries.
About the Global Life Sciences Practice
At Odgers Berndtson we pride ourselves on our ability to combine the specialist sector knowledge, insight and expertise of smaller ‘boutiques’ with the infrastructure and global reach of larger search firms. Our clients benefit from access to an established global network, but also from a flexible approach to partnership. Our Global Life Sciences Practice is a diverse and highly performing team of over 30 specialists who operate across the full spectrum of subsectors including Global Biopharma and Med-Tech; early stage VC/PE and public companies; Diagnostics and Medical Devices; Consumer Health; Bioinformatics, analytics and digital health; and pharma services. We have a strong presence in the key Life Sciences hubs around the world as well as the important emerging markets of Asia Pacific and Latin America.